Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements

Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements This document provides guidance on brand name assessment, inner and outer product labels, and risk management planning. 2022-07-28 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19SARS-CoV-2 virusCOVID-19 vaccinesCOVID-19 drugsmarket authorization requirementslabelling requirementspost-market requirements Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirementsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/guidance-market-authorization-vaccines/labelling-post-market-requirements.html Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirementsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/ligne-directrices-autorisations-mise-marche-vaccins/exigences-etiquetage-post-commercialisation.html

This document provides guidance on brand name assessment, inner and outer product labels, and risk management planning.

Data and Resources

Similar records